drugset / Trial / NCT07545720

Pinoxin for the Prevention of Radiation-Induced Skin Injury

NCT07545720 ↗

Phase 2 Recruiting 202 enrolled Fudan University
RandomizedParallel-groupSingle-blindPrevention

Summary

The incidence of radiation-induced skin injury is high, and effective preventive measures are currently lacking. This study evaluates the role of the skin protective agent Pinoxin in preventing skin injury. Patients are randomly assigned into two prospective groups: treatment group and control group. In treatment group, patients will receive Pinoxin treatment. In control group,patients will receive placebo treatment. The rate of grade 2 or greater skin injury will be analyzed.

Timeline

Start
2024-09-05
Primary completion
2026-05-31
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject pinoxin Unknown — Topical

Indications

No indication recorded.